UCFI CN Healthy Food Tech Group Corp.
Food and Kindred Products · Nasdaq · SEC CIK 1901203 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY-5.3%
TTM net income YoY-56.3%
TTM EPS YoY-61.1%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin72.7%
Operating margin35.4%
Net margin16.0%
FCF margin-65.8%
EBITDA margin37.2%
Returns
ROE19.3%
ROA9.0%
ROIC (approx.)—
Asset turnover0.56x
Leverage & solvency
Liabilities / assets26.8%
Debt / equity0.00x
Current ratio2.90x
Interest coverage19.05x
Cash quality & payout
Operating cash flow / net income-4.05x
Accruals ratio45.4%
Payout ratio—
Capex / revenue1.1%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $2.46M | $8.73M | $5.83M | $7.88M | $7.91M | $7.46M | $4.82M | $6.09M |
| Cost of revenue | $824,532 | $2.49M | $1.46M | $2.02M | $2.34M | $2.52M | $2.47M | $2.02M |
| Gross profit | $1.63M | $6.24M | $4.36M | $5.85M | $5.57M | $4.94M | $2.36M | $4.08M |
| R&D expense | $37,143 | $35,550 | $38,370 | $37,072 | $37,844 | $30,861 | $27,483 | — |
| SG&A expense | $793,797 | $763,319 | $3.07M | $2.80M | $438,067 | $602,431 | $415,840 | $360,633 |
| Operating income | $435,274 | $5.12M | $730,616 | $2.52M | $4.58M | $3.87M | $805,198 | $2.87M |
| Interest expense | $131,316 | $129,887 | $206,021 | -$5,122 | -$10,139 | $5,609 | — | -$2,167 |
| Pretax income | $154,346 | $4.57M | $541,540 | $2.67M | $4.72M | $4.03M | $898,795 | $2.92M |
| Income tax | $298,353 | $1.51M | $850,537 | $1.30M | $1.38M | $1.11M | $125,112 | $846,231 |
| Net income | -$144,007 | $3.06M | -$308,997 | $1.37M | $3.34M | $2.92M | $773,683 | $2.07M |
| EBITDA | $547,568 | $5.23M | $839,866 | $2.65M | $4.81M | $3.94M | $856,131 | $2.95M |
| EPS (basic) | -0.00 | 0.06 | -0.01 | — | 0.07 | 0.06 | 0.02 | — |
| EPS (diluted) | -0.00 | 0.06 | -0.01 | — | 0.07 | 0.06 | 0.02 | — |
| Weighted avg. shares (diluted) | 52.23M | 52.23M | 52.23M | — | 47.69M | 47.69M | 47.69M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $21.52M | $23.32M | $29.69M | $33.01M | $37.21M | $40.22M | $41.39M | $41.43M |
| Receivables | $2,212 | $1,011 | — | $287 | — | — | — | $845 |
| Inventory | $2.06M | $2.21M | $850,946 | $956,407 | $1.85M | — | — | $1.25M |
| Current assets | $25.00M | $27.52M | $31.36M | $36.89M | $46.18M | $155,014 | $79,672 | $44.02M |
| PP&E, net | $4.32M | $4.52M | $4.57M | $4.61M | — | — | — | $4.04M |
| Intangibles | $86,087 | $87,144 | $83,000 | $83,728 | $86,266 | — | — | $49,286 |
| Total assets | $32.19M | $35.21M | $39.12M | $44.73M | $56.23M | $73.32M | $73.65M | $50.75M |
| Current liabilities | $8.63M | $11.74M | $19.03M | $24.61M | $38.19M | $72.44M | $3.36M | $39.94M |
| Total liabilities | $8.63M | $11.86M | $19.22M | $24.85M | $38.49M | $74.95M | $5.88M | $39.94M |
| Shareholders' equity | $23.56M | $23.35M | $19.90M | $19.87M | $17.75M | $14.74M | $11.64M | $10.81M |
| Shares outstanding | 52.23M | 52.23M | 52.23M | 52.23M | 52.23M | 1.97M | 1.97M | 47.69M |
| Cash flow statement | ||||||||
| Operating cash flow | -$2.13M | -$7.03M | -$3.60M | -$3.34M | -$3.66M | -$1.31M | -$165,415 | $20.26M |
| Capital expenditure | $9 | $14 | $1,554 | $266,137 | $176,796 | $194,337 | $73,366 | — |
| Free cash flow | -$2.13M | -$7.03M | -$3.60M | -$3.60M | -$3.84M | -$1.50M | -$238,781 | — |
| Investing cash flow | -$157 | -$5,019 | -$1,638 | -$266,960 | -$1.72M | -$372,510 | -$75,258 | $2.76M |
| Financing cash flow | $0 | $0 | $116,000 | -$1.01M | $35,491 | $510,230 | $471,041 | $724,783 |
| Depreciation & amortization | $112,294 | $111,257 | $109,250 | $132,067 | $223,942 | $61,220 | $50,933 | $83,578 |
Free plan shows the latest 8 periods; Pro shows all 15 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.